The MSCI World index, which includes 1,603 companies across 23 developed markets, didn't beat it's all-time monthly record, but did close up 12.66% for the month.
The pan-European Stoxx 600 index, meanwhile, clocked up its best-ever month in November, ending 13.73% higher.
Elsewhere across the world, the MSCI Asia ex-Japan index gained 8% in November and the MSCI Emerging Markets Index was up 9.2%.
The month's rally has also been characterized by an apparent rotation towards cyclical stocks, whose performance tends to align with the trajectory of the global economy.
Investors have also opted for value stocks — those deemed underpriced relative to their fundamentals — over growth stocks like the big tech names which had driven much of the market recovery from March's crash.
it's, Joe Biden
New York Stock Exchange, Dow Jones Industrial, Nasdaq, Pfizer, BioNTech, Moderna, AstraZeneca, U.S, Investors
U.S, Asia, Japan